M K Proteins Limited has informed the Exchange regarding Board meeting held on August 12, 2025.
MKPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
M K Proteins' board approved un-audited Q1 FY26 results (quarter ended 30 June 2025) showing revenue from operations of Rs. 114.95 crore, more than double the Rs. 57.33 crore reported in Q1 FY25. Profit after tax rose to Rs. 3.51 crore from Rs. 2.48 crore, a growth of about 42% year-on-year. The statutory auditor M/s KRA & Co. resigned effective 12 August 2025, with the company stating no concerns were raised; M/s Subhash Sajal & Associates has been appointed to fill the casual vacancy until the 13th AGM. M/s J.P. Jagdev & Co. has also been appointed as secretarial auditor for a five-year term from FY25-26 to FY29-30. The limited review report issued by the outgoing auditor was clean, with no qualifications or observations.
Strong top-line doubling and healthy profit growth in Q1 are positive for shareholders, though EBITDA margins appear to have compressed compared to last year, suggesting rising input costs. The mid-year change of statutory auditor, while the company cites no concerns, is a governance event investors should watch closely.